These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3433716)
21. [Antiviral activity of remantadine evaluated by a pathomorphological study of the lungs of mice infected by influenza virus]. Denys A; Korczak E; Kulig A; Błoch P; Sygut J Med Dosw Mikrobiol; 1984; 36(4):231-8. PubMed ID: 6535053 [No Abstract] [Full Text] [Related]
22. Antiviral action of dipyridamole and its derivatives against influenza virus A. Tonew E; Indulen MK; Dzeguze DR Acta Virol; 1982 May; 26(3):125-9. PubMed ID: 6127012 [TBL] [Abstract][Full Text] [Related]
23. [Electron microscopic study of the antiviral action of bonafton in experimental influenza infection]. Stebaeva LF; Nikolaeva IS; Botkina EM; Pershin GN Farmakol Toksikol; 1980; 43(6):708-14. PubMed ID: 7450010 [TBL] [Abstract][Full Text] [Related]
24. [An experimental study of ADP-ribosylation inhibitors as anti-influenza agents]. Vladimirov VG; Krasil'nikov II; Volgarev AP; Platonov VG Vopr Virusol; 1991; 36(4):293-5. PubMed ID: 1796583 [TBL] [Abstract][Full Text] [Related]
25. Combined protective effect of a fungal Cu/Zn-containing superoxide dismutase and rimantadine hydrochloride in experimental murine influenza a virus infection. Serkedjieva J; Roeva I; Angelova M; Dolashka P; Voelter WG Acta Virol; 2003; 47(1):53-6. PubMed ID: 12828346 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of influenza virus replication by plant-derived isoquercetin. Kim Y; Narayanan S; Chang KO Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184 [TBL] [Abstract][Full Text] [Related]
27. [Inhibiting action of adamantane derivatives on chronic influenzal infection in a tissue culture]. Shobukhov VM; Linitskaia GL; Galegov GA Vopr Virusol; 1983; (3):325-30. PubMed ID: 6613090 [TBL] [Abstract][Full Text] [Related]
28. Regulation of influenza virus-caused oxidative stress by Kegan Liyan oral prescription, as monitored by ascorbyl radical ESR signals. Duan S; Gu L; Wang Y; Zheng R; Lu J; Yin J; Guli L; Ball M Am J Chin Med; 2009; 37(6):1167-77. PubMed ID: 19938224 [TBL] [Abstract][Full Text] [Related]
29. Synergistic combination of N-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse model. Ghezzi P; Ungheri D Int J Immunopathol Pharmacol; 2004; 17(1):99-102. PubMed ID: 15000873 [TBL] [Abstract][Full Text] [Related]
30. [Factors of antiviral resistance in the pathogenesis of influenza in mice]. Chetverikova LK; Ki'ldivatov IIu; Inozemtseva LI; Kramskaia TA; Filippov VK; Frolov BA Vestn Akad Med Nauk SSSR; 1989; (11):63-8. PubMed ID: 2623936 [TBL] [Abstract][Full Text] [Related]
31. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. McCullers JA J Infect Dis; 2004 Aug; 190(3):519-26. PubMed ID: 15243927 [TBL] [Abstract][Full Text] [Related]
32. [Synthesis of virus-specific RNA in influenza virus-infected cells in the presence of bonafton]. Gerasina SF; Farashian VR; Fadeeva NI; Pershin GN; Zhdanov VM Farmakol Toksikol; 1985; 48(4):92-5. PubMed ID: 2412888 [No Abstract] [Full Text] [Related]
33. [Characteristics of the degree and spectrum of antiviral activity of 2-(1'-aminoethyl)-bicyclo[2.2.1]heptane hydrochloride]. Votiakov VI; Boreko EI; Rusiaev VA; Shashikhina MN; Kazak NF Vopr Virusol; 1982; 27(2):172-6. PubMed ID: 7090343 [TBL] [Abstract][Full Text] [Related]
34. [Stimulating action of liposomes on experimental influenza infection]. Petrova IG; Slepushkin VA; Bukrinskaia AG Vopr Virusol; 1988; 33(6):662-3. PubMed ID: 3247685 [TBL] [Abstract][Full Text] [Related]
35. [Remantadine and 4-iodoantipyrine in the treatment and prevention of experimental influenza infection]. Evstropov AN; Iavorovskaia VE; Galegov GA Vopr Virusol; 1989; 34(6):734-8. PubMed ID: 2483783 [No Abstract] [Full Text] [Related]
36. [Immunotherapy with taktivin and myelolipid in experimental influenzal infection]. Aleksandrova NN; Arion VIa; Slobodeniuk AV; Sanina IV Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):89-92. PubMed ID: 2816187 [TBL] [Abstract][Full Text] [Related]
37. High protection of animals lethally infected with influenza virus by aprotinin-rimantadine combination. Zhirnov OP J Med Virol; 1987 Feb; 21(2):161-7. PubMed ID: 2434613 [TBL] [Abstract][Full Text] [Related]
38. [The protective effect of peptides from the thymus and tracheal mucosa in an experimental respiratory influenzal infection]. Khavinson VKh; Kozhemiakin AL; Volgarev AP; Platonov VG Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):68-73. PubMed ID: 8067076 [TBL] [Abstract][Full Text] [Related]
39. Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice. Sidwell RW; Huffman JH; Gilbert J; Moscon B; Pedersen G; Burger R; Warren RP Antimicrob Agents Chemother; 1992 Feb; 36(2):473-6. PubMed ID: 1605614 [TBL] [Abstract][Full Text] [Related]